Scaled Biolabs

Things happening back home! We were excited to host the Chief Scientist of Queensland, Prof Paul Bertsch, at Scaled for a tour and some real talk! Thanks #tradeinvestqueensland #tiq for facilitating!

Dropped in @CellStemCell - Thousands of human cardiac organoids used to discover heart regeneration drugs that don't cause arrythmias... by Scaled friends Richard Mills, @jehudson85, @PorrelloER, et al. doi.org/10.1016/j.stem…

High-Performance Medicine: my @NatureMedicine review of #AI and where we're headed nature.com/articles/s4159… (open-access for 30 days)

Today we join with @3ScanTweets @Prellisbio and friends to showcase new cell-focused technologies for biotech globenewswire.com/news-release/2… #JPM19 #JPM2019

"An efficient, scalable manufacturing process is critical". Kicking off this year's #JPM19 @alliancerm @Celgene

Progress on predicting #protein structures using #AI out of @DeepMindAI. "...CASP organizers have called 'unprecedented progress in the ability of computational methods to predict protein structure'". deepmind.com/blog/alphafold/

CEO Drew Titmarsh delivering our approach and @PlateletBioGen announcement @SynBioBeta today #synbiobeta2018. Come chat more @indbio tonight if you're about!

"The agreement follows a successful pilot program that has boosted the performance economics of a critical stage of #platelet production by almost an order of magnitude." Super excited about our next chapter with @PlateletBioGen (plateletbiogenesis.com) #synbiobeta2018

We're proud to announce our latest collaboration. Working with Platelet BioGenesis (@PlateletBioGen), we will unlock a robust, economical and streamlined process for making human #Platelets! Details: businesswire.com/news/home/2018…

Brace for impact. We're proud to kick off #SynBioBeta2018 with an exciting announcement. Be sure to tune in during the "Biopharma & Healthcare" session tomorrow @SynBioBeta (Room 1, 1.40pm) to hear our CEO, Drew Titmarsh (@dmtxbio), spill the details. More info coming soon!

Join our #synbiobeta2018 session on how #synbio has become the cutting edge in #pharma & #healthcare w/ @OxfordGenetics, @MSo_nightingale @SyntheX_Labs, @DavidAYounger @AAlphaBio, @eGenesisBio, @melanie_matheu @PrellisBio @dmtxbio @ScaledBiolabs bit.ly/2pi9SbA

"Biology first, modality second" Ai Ching Lim @Amgen in #mbcbiolabs seminar series @QB3 today.

It was a fantastic "Regenerative Medicine" event last night with @Prellisbio @ScaledBiolabs @Convalesce_Inc at @SheppardMullin in Palo Alto. @junaxup #IndieBio

Regenerative medicine event tonight with @Prellisbio @ScaledBiolabs @Convalesce_Inc at @SheppardMullin in Palo Alto

Our legendary Lead Scientist Dr. Kelly Haston sharing our vision @indbio's stem cell Meetup event @Stanford tonight. Let us know if you're about!

FYI! @sloan_kettering @BerkeleyPostdoc @GladPostdocs @PostdocsUCSF @wyssinstitute @harvardstemcell @AusStemCell

Positions open! Come work with a multidisciplinary team on the cutting edge of #microfluidics, #automation, and #machinelearning to develop next generation regenerative cell therapies. Full time salary, equity and generous time off. Apply today! scaledbiolabs.com/careers.html

Want to work with a multidisciplinary team on the cutting edge of regenerative cell therapies, using microfluidics, automation, and machine learning? Check out our new openings: scaledbiolabs.com/careers.html

A study of 128 drugs FDA approved between 2010-2014. "Median initiation was 1974, with a median of 25 years to the established point, 28 years to first clinical trials, and 36 years to FDA approval" via Laura McNamee (@LMac0630) et al. buff.ly/2JL9DCx @PLOS #motivation

Nice data-driven piece. "Cancer Drug Response Profile scan: A Deep Learning Model That Predicts Drug Effectiveness from Cancer Genomic Signature" via Chang et al. @Syntekabio @SciReports